Company Presentation • 15 Dec 2020 16:22
Virtual Investor Day Presentation
Company Presentation • 15 Dec 2020 16:07
Third Quarter 2020 Earnings Call Presentation
No more presentations
𝛼SK or SearchENTITY
Alexion Pharmaceuticals (ALXN US)
Alexion Pharmaceuticals (ALXN US)
39
Analysis
Health Care • United States
Alexion Pharmaceuticals, Inc., a biopharmaceutical company, researches and develops proprietary immunoregulatory compounds for the treatment of autoimmune and cardiovascular diseases. The Company develops C5 complement inhibitors and Apogens which are two classes of potential therapeutic compounds designed to selectively target specific disease-causing segments of the immune system.
morex